BACKGROUND: Although studies have shown that complementary and alternative medicine (CAM) use is common in cancer patients, no survey has assessed CAM use in men with a variety of cancers. In Australia, no data exist about male cancer patients' use of CAM. PATIENTS AND METHODS: A self-administered questionnaire was completed by 403 men attending four cancer outpatient services in Metropolitan Adelaide. Data were analyzed using Pearson's χ(2) tests and multivariate logistic regression analysis. RESULTS: CAMs were currently used by 52.9%, or used at some point by 61.5%, of respondents. The most popular CAM treatments were dietary supplements (36.1%), prayer (25.9%), herbs and botanicals (21.4%), and relaxation techniques/meditation (15.2%). CAM use was directed by a cancer specialist in 9.9% of respondents. Independent predictors of CAM use were metastatic cancer (P = 0.022), actively practicing religion (P = 0.008), and tertiary education (P = 0.007). CONCLUSIONS: CAM use in males is equally common across all cancer diagnoses, namely prostate, hematological malignancies, colorectal, lung, and other cancers. Oncologists should be aware that one-third of male patients modify their diet and/or search for spiritual guidance, particularly when diagnosed with metastatic cancer.
BACKGROUND: Although studies have shown that complementary and alternative medicine (CAM) use is common in cancerpatients, no survey has assessed CAM use in men with a variety of cancers. In Australia, no data exist about male cancerpatients' use of CAM. PATIENTS AND METHODS: A self-administered questionnaire was completed by 403 men attending four canceroutpatient services in Metropolitan Adelaide. Data were analyzed using Pearson's χ(2) tests and multivariate logistic regression analysis. RESULTS: CAMs were currently used by 52.9%, or used at some point by 61.5%, of respondents. The most popular CAM treatments were dietary supplements (36.1%), prayer (25.9%), herbs and botanicals (21.4%), and relaxation techniques/meditation (15.2%). CAM use was directed by a cancer specialist in 9.9% of respondents. Independent predictors of CAM use were metastatic cancer (P = 0.022), actively practicing religion (P = 0.008), and tertiary education (P = 0.007). CONCLUSIONS: CAM use in males is equally common across all cancer diagnoses, namely prostate, hematological malignancies, colorectal, lung, and other cancers. Oncologists should be aware that one-third of male patients modify their diet and/or search for spiritual guidance, particularly when diagnosed with metastatic cancer.
Authors: Ralph Muecke; Magdalena Paul; Christina Conrad; Christoph Stoll; Karsten Muenstedt; Oliver Micke; Franz J Prott; Jens Buentzel; Jutta Huebner Journal: Integr Cancer Ther Date: 2015-07-26 Impact factor: 3.279
Authors: Magda Paul; B Davey; B Senf; C Stoll; K Münstedt; R Mücke; Oliver Micke; F J Prott; J Buentzel; Jutta Hübner Journal: J Cancer Res Clin Oncol Date: 2013-07-06 Impact factor: 4.553
Authors: J Kleine Wortmann; A Bremer; H T Eich; H P Kleine Wortmann; A Schuster; J Fühner; J Büntzel; R Muecke; F J Prott; J Huebner Journal: Med Oncol Date: 2016-06-14 Impact factor: 3.064
Authors: Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney Journal: Support Care Cancer Date: 2014-02-21 Impact factor: 3.603
Authors: John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki Journal: Evid Based Complement Alternat Med Date: 2021-05-17 Impact factor: 2.650
Authors: Ji-Yeon Shin; So Young Kim; Boyoung Park; Jae-Hyun Park; Jin Young Choi; Hong Gwan Seo; Jong-Hyock Park Journal: Evid Based Complement Alternat Med Date: 2012-12-24 Impact factor: 2.629